Results 31 to 40 of about 24,763,168 (195)

Nephrogenic systemic fibrosis (NSF) and gadolinium-based contrast media

open access: yesSouth African Journal of Radiology, 2013
Nephrogenic systemic fibrosis (NSF), unknown before March 1997 and first described in 2000, is a systemic disorder characterised by widespread tissue fibrosis.
P.S. Ngoya, Z Vawda, J.W Lotz
doaj   +1 more source

Retrospective analysis of patients for development of nephrogenic systemic fibrosis following conventional angiography using gadolinium-based contrast agents [PDF]

open access: yes, 2010
The purpose was to retrospectively review the data of 27 patients with renal insufficiency who underwent conventional angiography with gadolinium-based contrast agents (GDBCA) as alternative contrast agents and assess the occurrence of nephrogenic ...
Nievergelt, Helga   +6 more
core   +2 more sources

Altered Plasma Mitochondrial Metabolites in Persistently Symptomatic Individuals after a GBCA-Assisted MRI

open access: yesToxics, 2022
Despite the impressive safety of gadolinium (Gd)-based contrast agents (GBCAs), a small number of patients report the onset of new, severe, ongoing symptoms after even a single exposure—a syndrome termed Gadolinium Deposition Disease (GDD). Mitochondrial
DeAunne Denmark   +4 more
doaj   +1 more source

Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up [PDF]

open access: yes, 2018
PURPOSE:We aimed to determine the incidence rate and potential risk factors for postcontrast acute kidney injury (PC-AKI) as well as the long-term clinical implications on dialysis and mortality in patients with chronic kidney disease (CKD) who underwent
William S. Harmsen   +4 more
core   +1 more source

Critical Questions Regarding Gadolinium Deposition in the Brain and Body After Injections of the Gadolinium-Based Contrast Agents, Safety, and Clinical Recommendations in Consideration of the EMA's Pharmacovigilance and Risk Assessment Committee Recommendation for Suspension of the Marketing Authorizations for 4 Linear Agents. [PDF]

open access: yes, 2017
For magnetic resonance, the established class of intravenous contrast media is the gadolinium-based contrast agents. In the 3 decades since initial approval, these have proven in general to be very safe for human administration.
Val M. Runge, Runge, Val Murray
core   +2 more sources

Synthesis of a gadolinium based-macrocyclic MRI contrast agent for effective cancer diagnosis

open access: yesBiomaterials Research, 2018
Background Gadolinium-based contrast agents are widely used as a contrast agent for magnetic resonance imaging. Since gadolinium ions are toxic, many chelators are developed to bind gadolinium ions to prevent free gadolinium-associated disease.
Yohan Jeong, Kun Na
doaj   +1 more source

Correction to: Gadolinium-Based Contrast Agent-Related Toxicities [PDF]

open access: yesCNS Drugs, 2018
The name of the last author (as shown in the author listing on page 229) was incorrectly tagged during the journal production process, and so appears incorrectly in the PubMed record. The name should be indexed in PubMed as.
Pasquini, Luca   +6 more
openaire   +4 more sources

Safety of the Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging, Focusing in Part on Their Accumulation in the Brain and Especially the Dentate Nucleus. [PDF]

open access: yes, 2016
The established class of intravenous contrast media for magnetic resonance imaging is the gadolinium chelates, more generally referred to as the gadolinium-based contrast agents (GBCAs). These can be differentiated on the basis of stability in vivo, with
Runge, Val Murray
core   +2 more sources

Gadolinium-Based Contrast Media Nephrotoxicity. Overview and Recommendations [PDF]

open access: yes, 2023
Gadolinium-based contrast media (GBCM), gadolinium-based contrast agents (GBCAs), or simply gadolinium contrast agents, are molecular complexes containing the rare earth metal gadolinium chelated to a carrier ligand.
Djendov, Veselin R.; Department of Surgery, University Hospital, Burgas, Bulgaria   +1 more
core   +1 more source

Gadolinium-based Contrast Agents: The Plot Thickens [PDF]

open access: yesRadiology, 2017
Data are now accumulating to suggest that significant stratifications may exist within the classes of macrocyclic and linear gadolinium-based contrast agents, which may blur the perceived quantification borders between these two groups.
openaire   +2 more sources

Home - About - Disclaimer - Privacy